Tong Zhu, PhD, FCP

Dr. Tong Zhu has over 25 years of experience specializing in translational medicine, early development, and clinical pharmacology. She has a wealth of knowledge in pharmaceutical research and development. She was responsible for leading Astellas’ Primary Focus strategy in Mitochondria Biology by working globally to help identify and develop innovative drugs targeting mitochondrial biology. In almost 14 years at the company, she held various leadership positions in its Clinical Pharmacology & Exploratory Development division. Before her time at Astellas, Dr. Zhu held positions with increasing responsibilities at Abbott Global Pharmaceutical Research and Development (now AbbVie) on Clinical Pharmacology and Pharmacometrics teams.